CA03879J1003
CA03879J1003
Arbutus Biopharma Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 14.083.000 | 6.171.000 | 128.2% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 41.134.000 | 76.145.000 | 46.0% | |
| Operating Income | -27.051.000 | -69.974.000 | 61.3% |
| Pretax Income | -33.501.000 | -69.920.000 | 52.1% |
| Net Income Common Stockholders | -33.501.000 | -69.920.000 | 52.1% |
| -- | -- | -- | |
| -- | -- | -- |